Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
Xin Hu(Discovery Institute), Matthew D. Hall(National Institutes of Health), T. Jake Liang(National Institutes of Health), Wei Zheng(Liaoning Cancer Hospital & Institute), Zina Itkin(National Institutes of Health), Min Shen(Kaili University), Zongyi Hu(National Institutes of Health), Miao Xu(Shandong University), Hui Guo(First Affiliated Hospital of Xi'an Jiaotong University), Paul Shinn(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Parker Ivin(National Institutes of Health), Madeleine Leek(National Institutes of Health)
Cited by 23
Related Papers
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection
|Gastroenterology|2011|310